Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 39.58 USD 0.05%
Market Cap: 564.6m USD
Have any thoughts about
Surmodics Inc?
Write Note

Operating Margin
Surmodics Inc

-4.5%
Current
-5%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4.5%
=
Operating Profit
-5.6m
/
Revenue
126.1m

Operating Margin Across Competitors

Country US
Market Cap 564.7m USD
Operating Margin
-4%
Country US
Market Cap 205.2B USD
Operating Margin
17%
Country US
Market Cap 193.1B USD
Operating Margin
26%
Country US
Market Cap 148.6B USD
Operating Margin
22%
Country US
Market Cap 132.9B USD
Operating Margin
18%
Country IE
Market Cap 109.9B USD
Operating Margin
19%
Country US
Market Cap 64.8B USD
Operating Margin
14%
Country DE
Market Cap 56.6B EUR
Operating Margin
12%
Country CN
Market Cap 326.2B CNY
Operating Margin
36%
Country US
Market Cap 42.2B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

Surmodics Inc
Glance View

Market Cap
564.7m USD
Industry
Health Care

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.

SRDX Intrinsic Value
15.4 USD
Overvaluation 61%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4.5%
=
Operating Profit
-5.6m
/
Revenue
126.1m
What is the Operating Margin of Surmodics Inc?

Based on Surmodics Inc's most recent financial statements, the company has Operating Margin of -4.5%.